drug · protein
romiplostim
Phase 3updated 5mo agoby $AMGN AMGEN INC🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 1Protein drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 8 investigational indications.
targets
Thrombopoietin receptor
all catalysts(0)
nothing on the calendar yet
Trials studying romiplostim
- phase2Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation
- phase2High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- phase2Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
- phase3Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
- phase3Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
- phase3A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia
- phase2Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
- phase2Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that